DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
If you're worried about tying up your cash, one solution is a no-penalty CD. A no-penalty CD comes with terms ranging from ...
New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...
A conservative transfusion approach after general and vascular surgery was shown to be safe vs. earlier, less restrictive ...
When compared to published data with inclisiran, a small interfering RNA (siRNA) molecule that inhibits production of the PCSK9 enzyme, the data showed lipid lowering for LDL-C, non-HDL-C, ApoB, and ...
As experts warn that flu season may start earlier this year, they say over-the-counter generic drugs may offer the same ...
GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...
Third quarter 2025 revenue of $9.5 million, up 10% year-over-year Amended credit agreement with Avenue Capital Group which strengthens our balance sheet with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback